Haleon
Company type | Public limited company |
---|---|
ISIN | GB00BMX86B70 |
Industry | |
Predecessor | GSK Consumer Healthcare |
Founded | 18 July 2022 |
Headquarters | Weybridge, England, UK |
Area served | Worldwide |
Key people |
|
Products |
|
Brands | |
Revenue | £9,545 million (2021)[1] |
£1,638 million (2021)[1] | |
£1,439 million (2021)[1] | |
Total assets | £34,451 million (2021)[1] |
Owners | |
Number of employees | 22,000+ (2022)[2] |
Website | www |
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is the largest consumer healthcare business in the world,[3] with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins.[4] The company is a global leader in over the counter medicines with a 7.3 percent market share.[5]
Haleon was established on 18 July 2022 as a corporate spin-off from GSK.[6]
Sir David Lewis is chairman, with Brian McNamara as CEO.[7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020.[5]
History
GSK and Pfizer merged their consumer healthcare businesses in 2019.[8] GSK owned just over two thirds of the joint venture, and Pfizer held the remainder.[8]
GSK announced plans to spin-off Haleon in 2018 in order to give the "tired drugmaker extra focus and firepower by gearing up and hiving off the consumer division".[9]
Unilever offered £50 billion for the business in 2022, in a bid which GSK rejected.[10] Nestlé examined the possibility of a bid in conjunction with Reckitt.[11]
Operations
Oral health accounted for 28.5 percent of revenue in 2021.[12]
Gross assets amounted to over £45 billion on 31 March 2022.[12]
Brands
Brands include:[13]
- Abreva (Docosanol)
- Advil (Ibuprofen)
- alli (Orlistat)
- Aquafresh (oral healthcare)
- Astring-o-Sol (oral healthcare)
- Be-Total (leader in vitamins market in Italy)
- Beechams Cold & Flu and Night/Day Nurse (cold and flu treatments)
- Biotene (oral healthcare)
- Boost (nutritional)
- Breathe Right (respiratory)
- Centrum (vitamins and naturals)
- Cetebe (vitamins and naturals)
- Chlorhexamed (oral healthcare)
- Cholinex (analgesics and respiratory tract)
- Citrucel (gastrointestinal)
- Coldrex (cold and flu treatment)
- Commit Lozenge (smoking cessation)
- Committed Quitters (nicotine replacement)
- Corega (oral healthcare)
- Corsodyl (oral healthcare)
- Crocin (analgesics and respiratory tract)
- Dr. Best (oral healthcare)
- ENO (gastrointestinal)
- Eumovate (dermatological)
- Fenbid (analgesics and respiratory tract)
- Flonase (fluticasone propionate)
- Formigran (analgesic/triptan)
- Grand-PA (headache/toothache/pain and fever)
- Hinds (dermatological)
- Junior Horlicks (nutritional)
- Iodex (pain relief)
- Iodosan (cold and flu treatment)
- Macleans (oral healthcare)
- Maltova (nutritional)
- Maxinutrition (nutritional)
- Med-Lemon (hot, cold and flu medication)
- Medacalm (vitamins and naturals)
- Nicorette (nicotine replacement)
- Night Nurse (cold and flu remedy)
- NiQuitin CQ/ Nicoderm CQ/ Nicabate (nicotine replacement)
- Odol (oral healthcare)
- Odol-med3 (oral healthcare)
- Os-cal (oral healthcare)
- Panadeine (analgesics and respiratory tract)
- Panadol (analgesics and respiratory tract)
- parodontax (oral healthcare)
- Piriton/Piriteze (anti-allergy)
- Polident (oral healthcare)
- Poligrip Ultra (oral healthcare)
- Rutinoscorbin (vitamins and naturals)
- Scott's Emulsion (vitamins and naturals)
- Sensodyne (oral healthcare)
- Shumitect (oral healthcare)
- Solpadeine (analgesics and respiratory tract)
- Super Poligrip (oral healthcare)
- Super Wernet's (oral healthcare)
- Synthol (oral healthcare)
- Theraflu (Respiratory)
- Tums (gastrointestinal)
- Viva (vitamins and naturals), origin: Nepal
- Zovirax (dermatological)
Ownership
As of 2022, Pfizer owns 32 percent of Haleon, while GSK retain a 13 percent stake.[9]
References
- ^ a b c d "Prospectus" (PDF). GSK plc. p. 131. Retrieved 10 June 2022.
- ^ Sweney, Mark; Kollewe, Julia (18 July 2022). "GSK spin-off Haleon begins trading in biggest European listing in a decade". The Guardian.
- ^ "GSK Completes Demerger of Consumer Healthcare Business". uk.news.yahoo.com. Retrieved 2022-11-15.
- ^ Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times. Retrieved 4 July 2022.
- ^ a b Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes. Retrieved 10 June 2022.
- ^ "Prospectus" (PDF). GSK plc. p. 15. Retrieved 10 June 2022.
- ^ Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News. Retrieved 10 June 2022.
- ^ a b Shane, Daniel (19 December 2018). "Advil meet Excedrin: Pfizer and GSK are merging their consumer healthcare businesses". CNN. Retrieved 10 June 2022.
- ^ a b Donnellan, Aimee (9 June 2022). "GSK castoff starts life with target on its back". Reuters. Retrieved 10 June 2022.
- ^ Jolly, Jasper (19 January 2022). "Unilever will not increase £50bn offer for GSK consumer arm". The Guardian. Retrieved 10 June 2022.
- ^ "Nestle Eyed Biggest-Ever Deal in Aborted Move for GSK Unit". Bloomberg News. 25 May 2022. Retrieved 10 June 2022.
- ^ a b "Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon". GSK. GSK. Retrieved 10 June 2022.
- ^ "Our Consumer Healthcare Brands". Haleon. Retrieved 19 July 2022.
External links
- Official website
- Business data for Haleon:
- Haleon
- 2022 establishments in England
- Companies based in Surrey
- Companies listed on the London Stock Exchange
- Corporate spin-offs
- Dental companies
- Health care companies of England
- Manufacturing companies of England
- Manufacturing companies established in 2022
- Multinational companies headquartered in England
- Personal care companies
- GSK plc
- Pfizer
- Weybridge, Surrey